Inhibition of mPGES-1 or COX-2 Results in Different Proteomic and Lipidomic Profiles in A549 Lung Cancer CellsFilip Bergqvist, Per‐Johan Jakobsson, Helena Idborg et al.|Frontiers in Pharmacology|2019Cited by 24